Esperion Therapeutics, Inc. short interest in 2022
In 2022, Esperion Therapeutics, Inc.'s disclosed short interest ran from 5.58% of shares outstanding on 15 Feb 2022 to 21.85% on 30 Dec 2022, a change of +16.27 percentage points. The year's high was 21.85% on 30 Dec 2022 and its low 5.58% on 15 Feb 2022, averaging 16.46% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.09 days on 29 Jul 2022. Full history: Esperion Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 5.58% (15 Feb 2022)
- End of year
- 21.85% (30 Dec 2022)
- Change
- +16.27 pp
- High
- 21.85% (30 Dec 2022)
- Low
- 5.58% (15 Feb 2022)
- Average
- 16.46%
- Highest days to cover
- 27.09 (29 Jul 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Feb 2022 | 5.58% | 3.03 | results (8-K) |
| 28 Feb 2022 | 6.60% | 3.52 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 8.55% | 4.70 | |
| 31 Mar 2022 | 11.68% | 5.19 | |
| 14 Apr 2022 | 12.70% | 6.53 | |
| 29 Apr 2022 | 13.97% | 6.53 | |
| 13 May 2022 | 16.15% | 4.95 | 10-Q filed, results (8-K) |
| 31 May 2022 | 18.35% | 11.81 | |
| 15 Jun 2022 | 17.57% | 14.13 | |
| 30 Jun 2022 | 18.76% | 12.10 | |
| 15 Jul 2022 | 19.25% | 21.22 | |
| 29 Jul 2022 | 19.87% | 27.09 | |
| 15 Aug 2022 | 18.47% | 12.01 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 20.06% | 7.97 | |
| 15 Sep 2022 | 18.95% | 10.69 | |
| 30 Sep 2022 | 18.78% | 13.02 | |
| 14 Oct 2022 | 20.03% | 12.29 | |
| 31 Oct 2022 | 19.05% | 13.29 | |
| 15 Nov 2022 | 18.59% | 10.25 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 18.14% | 11.63 | |
| 15 Dec 2022 | 19.13% | 3.09 | |
| 30 Dec 2022 | 21.85% | 10.21 |
See also: Esperion Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.